Wondering about the most recent progress in Myasthenia Gravis treatments research and clinical trials?
Wondering about the most recent progress in myasthenia gravis treatments research and clinical trials?
Join a “What’s New in MG Research” webinar to learn about the latest research results, key clinical trial phases, and current outcomes from top research trials taking place right now.
CAR-T Cell Therapy for Generalized Myasthenia Gravis: Introduction to anito-cel
Aug 21, 2025 01:00 PM Eastern Time (US and Canada)
Join us to learn about anito-cel, a novel BCMA-targeted DNA CAR T-cell therapy that is being developed by Arcellx for generalized myasthenia gravis (gMG). Dr. Chris Heery, Chief Medical Officer at Arcellx, will explain how CAR T-cell therapy works and introduce the clinical trial of anito-cel in gMG.
Sponsored by Arcellx.
Register Now
Presenting Partners
Recent Webinars
